Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.33 billion.
Market Cap
1.11T
Revenue
110.33B
Profits
-39.73B
PE Ratio
n/a
Profit Margin
-36.01%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.66B | -1.60% | 1,059,478 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 69.83B | -6.21% | 1,833,825 | 14.92B |
| 3 | ARGX | argenx SE | 47.71B | 0.13% | 423,338 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.19B | -0.30% | 1,561,569 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 32.31B | -2.47% | 208,697 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 29.56B | -2.96% | 2,790,508 | - |
| 7 | RPRX | Royalty Pharma plc | 29.34B | -0.10% | 3,050,535 | 2.38B |
| 8 | INSM | Insmed Incorporated | 29.15B | 0.07% | 1,487,674 | 606.42M |
| 9 | BNTX | BioNTech SE | 25.69B | -0.48% | 433,446 | 3.37B |
| 10 | INCY | Incyte Corporation | 19.80B | 1.39% | 2,242,659 | 5.36B |
| 11 | ROIV | Roivant Sciences Ltd. | 19.70B | -0.90% | 4,372,000 | 13.31M |
| 12 | MRNA | Moderna, Inc. | 18.13B | -3.01% | 5,478,314 | 1.94B |
| 13 | SMMT | Summit Therapeutics Inc. | 16.17B | -2.02% | 2,760,333 | - |
| 14 | GMAB | Genmab A/S | 15.90B | -2.63% | 1,837,688 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.75B | 1.76% | 2,791,521 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 13.61B | -0.81% | 1,671,887 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.36B | 4.25% | 3,675,223 | 1.06B |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.31B | -1.99% | 594,443 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | 0.37% | 153,836 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.35B | -0.53% | 1,857,471 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.48B | 1.71% | 1,639,573 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.88B | 0.57% | 1,044,937 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.41B | -0.57% | 758,563 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.00B | 0.39% | 363,560 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.66B | -3.30% | 860,769 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.25B | -2.40% | 1,161,197 | - |
| 27 | TECH | Bio-Techne Corporation | 8.13B | -2.92% | 1,376,341 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 7.79B | -2.79% | 390,281 | - |
| 29 | KRYS | Krystal Biotech, Inc. | 7.65B | -3.46% | 213,842 | 389.13M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.47B | -1.25% | 1,230,464 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.40B | -1.83% | 2,375,172 | 88.04M |
| 32 | IBRX | ImmunityBio, Inc. | 7.19B | - | 9,274,434 | 113.29M |
| 33 | ACLX | Arcellx, Inc. | 6.75B | - | - | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.65B | -2.79% | 754,528 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.29B | -2.66% | 576,687 | 46.02M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.20B | 4.75% | 1,808,221 | - |
| 37 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | -0.04% | 1,859,061 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.03% | 1,666,062 | 15.00M |
| 39 | BLTE | Belite Bio, Inc | 6.08B | -2.66% | 37,771 | - |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.06B | -3.91% | 679,708 | - |
| 41 | COGT | Cogent Biosciences, Inc. | 5.78B | -1.29% | 1,272,647 | - |
| 42 | CELC | Celcuity Inc. | 5.75B | -0.89% | 861,784 | - |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.75B | 0.27% | 760,013 | 521.31M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.61B | -2.45% | 580,786 | 189.76M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.52B | -0.92% | 1,754,798 | - |
| 46 | IMVT | Immunovant, Inc. | 5.49B | -0.15% | 1,767,052 | - |
| 47 | CGON | CG Oncology, Inc. | 5.47B | -1.22% | 636,798 | 4.04M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.39B | 2.24% | 1,725,109 | 7.50M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.35B | -8.13% | 4,238,876 | 1.73B |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.10% | 2,721,412 | 1.00B |
| 51 | CAI | Caris Life Sciences, Inc. | 5.02B | -3.63% | 2,496,344 | 812.03M |
| 52 | CORT | Corcept Therapeutics Incorporated | 5.00B | -0.06% | 1,235,593 | 761.41M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.96B | -2.89% | 1,829,122 | 616.29M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.88B | -2.59% | 1,539,713 | 3.51M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.55B | -0.20% | 509,937 | 2.04M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.51B | -3.21% | 252,190 | 268.09M |
| 57 | LEGN | Legend Biotech Corporation | 4.21B | -3.35% | 1,414,304 | 1.03B |
| 58 | KLRA | Kailera Therapeutics, Inc. | 4.17B | 3.95% | 681,101 | - |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.03B | 0.76% | 2,581,484 | 7.70M |
| 60 | MANE | Veradermics, Incorporated | 3.98B | 3.35% | 715,279 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | -2.07% | 1,310,392 | 1.07B |
| 62 | TVTX | Travere Therapeutics, Inc. | 3.70B | -1.93% | 1,396,882 | 490.73M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.63B | -3.27% | 2,949,307 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.63B | -0.10% | 119,129 | 803.79M |
| 65 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.45B | -4.01% | 1,607,955 | 588.99M |
| 66 | ORKA | Oruka Therapeutics, Inc. | 3.42B | -7.96% | 7,921,329 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | -1.01% | 619,022 | 22.50M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.27B | -1.74% | 1,211,050 | - |
| 69 | TNGX | Tango Therapeutics, Inc. | 3.18B | -12.25% | 3,870,983 | 62.38M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.03B | -2.70% | 1,121,012 | 247.00M |
| 71 | DNLI | Denali Therapeutics Inc. | 2.95B | -7.28% | 3,000,006 | - |
| 72 | BEAM | Beam Therapeutics Inc. | 2.94B | -3.86% | 1,562,770 | 139.74M |
| 73 | GPCR | Structure Therapeutics Inc. | 2.93B | -5.04% | 1,478,846 | - |
| 74 | ALMS | Alumis Inc. | 2.91B | -4.70% | 1,065,095 | 24.05M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.88B | -4.13% | 1,547,961 | - |
| 76 | ERAS | Erasca, Inc. | 2.83B | -7.98% | 12,264,741 | - |
| 77 | NKTR | Nektar Therapeutics | 2.81B | -0.73% | 851,311 | 55.23M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.80B | -3.95% | 1,109,001 | 376.07M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.04% | 2,381,822 | 190.41M |
| 80 | KOD | Kodiak Sciences Inc. | 2.71B | -3.87% | 392,075 | - |
| 81 | IMNM | Immunome, Inc. | 2.60B | -3.21% | 812,139 | 6.94M |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.58B | -2.29% | 357,853 | 451.36M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.57B | -3.42% | 920,808 | - |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.54B | -1.35% | 491,833 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.52B | -3.28% | 602,750 | 1.55M |
| 86 | IRON | Disc Medicine, Inc. | 2.52B | -1.92% | 585,083 | - |
| 87 | IDYA | IDEAYA Biosciences, Inc. | 2.46B | -3.41% | 1,005,651 | 218.71M |
| 88 | ADMA | ADMA Biologics, Inc. | 2.46B | -2.75% | 4,210,057 | 510.17M |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.38B | -3.53% | 3,651,772 | 15.36M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.37B | -1.43% | 2,058,743 | 673.00M |
| 91 | ZLAB | Zai Lab Limited | 2.33B | -6.28% | 699,932 | 460.16M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | -1.90% | 1,155,280 | 2.20B |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.11B | -1.27% | 868,425 | - |
| 94 | AAPG | Ascentage Pharma Group International | 2.10B | -2.26% | 5,200 | 82.08M |
| 95 | ADPT | Adaptive Biotechnologies Corporation | 2.08B | -3.63% | 1,261,296 | 276.98M |
| 96 | MESO | Mesoblast Limited | 2.05B | 2.17% | 152,180 | 65.38M |
| 97 | ZYME | Zymeworks Inc. | 2.05B | -0.39% | 824,408 | 105.97M |
| 98 | DFTX | Definium Therapeutics, Inc. | 2.04B | -3.67% | 1,341,985 | - |
| 99 | STOK | Stoke Therapeutics, Inc. | 2.02B | -2.73% | 586,038 | 184.42M |
| 100 | TYRA | Tyra Biosciences, Inc. | 2.01B | -3.64% | 1,174,217 | - |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.00B | -1.18% | 2,522,434 | 51.95M |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -4.74% | 1,301,865 | 283.06M |
| 103 | PHVS | Pharvaris N.V. | 1.95B | 5.71% | 961,464 | - |
| 104 | TRVI | Trevi Therapeutics, Inc. | 1.94B | -0.14% | 1,585,019 | - |
| 105 | CAPR | Capricor Therapeutics, Inc. | 1.88B | -4.47% | 762,042 | 11.13M |
| 106 | GLPG | Galapagos NV | 1.85B | -1.97% | 222,764 | 1.31B |
| 107 | INBX | Inhibrx Biosciences, Inc. | 1.82B | -4.47% | 326,559 | 1.30M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -2.27% | 2,438,002 | 172.35M |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 1.80B | -0.48% | 2,802,201 | 9.77M |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | 1.80B | -0.35% | 613,997 | 868.45M |
| 111 | ANAB | AnaptysBio, Inc. | 1.79B | -5.70% | 686,372 | 234.60M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.75B | -2.79% | 147,795 | - |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.74B | -3.23% | 12,199,479 | 74.68M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.72B | -2.75% | 834,808 | 71.78M |
| 115 | INVA | Innoviva, Inc. | 1.71B | -2.70% | 564,176 | 411.33M |
| 116 | VCEL | Vericel Corporation | 1.70B | -6.23% | 720,165 | 276.26M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.69B | -5.46% | 317,656 | - |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | 13.10% | 2,797,906 | 66.05M |
| 119 | VIR | Vir Biotechnology, Inc. | 1.63B | -1.95% | 1,308,030 | 68.56M |
| 120 | NBTX | Nanobiotix S.A. | 1.60B | 0.23% | 57,596 | 38.27M |
| 121 | GENB | Generate Biomedicines, Inc. | 1.58B | -0.56% | 283,560 | 31.89M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.58B | -2.19% | 229,970 | - |
| 123 | OCS | Oculis Holding AG | 1.57B | -1.01% | 209,460 | 1.51M |
| 124 | ATAI | AtaiBeckley Inc. | 1.51B | -4.85% | 3,603,921 | 4.09M |
| 125 | NUVB | Nuvation Bio Inc. | 1.51B | -4.82% | 3,037,305 | 62.90M |
| 126 | IMTX | Immatics N.V. | 1.50B | -3.36% | 278,460 | 56.67M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -1.53% | 536,520 | 123.67M |
| 128 | ARDX | Ardelyx, Inc. | 1.47B | 0.67% | 3,390,780 | 407.32M |
| 129 | NTLA | Intellia Therapeutics, Inc. | 1.47B | -5.72% | 26,793,595 | 67.67M |
| 130 | PGEN | Precigen, Inc. | 1.46B | 2.49% | 2,904,061 | 9.68M |
| 131 | DMRA | Damora Therapeutics, Inc. | 1.44B | -1.24% | 118,080 | - |
| 132 | MAZE | Maze Therapeutics, Inc. | 1.42B | -1.00% | 412,647 | 2.50M |
| 133 | IMCR | Immunocore Holdings plc | 1.42B | -3.02% | 505,327 | 400.02M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.39B | -2.92% | 393,413 | - |
| 135 | BHVN | Biohaven Ltd. | 1.38B | -4.27% | 1,513,702 | - |
| 136 | VRDN | Viridian Therapeutics, Inc. | 1.37B | -2.28% | 981,016 | 70.85M |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 38.62% | 71,971,935 | 73.62M |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 1.36B | -2.07% | 8,938,445 | 263.50M |
| 139 | MBX | MBX Biosciences, Inc. | 1.36B | -1.48% | 296,668 | - |
| 140 | WVE | Wave Life Sciences Ltd. | 1.36B | -6.25% | 4,267,080 | 71.80M |
| 141 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -0.07% | 201,211 | - |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.33B | 0.03% | 252,078 | - |
| 143 | NVAX | Novavax, Inc. | 1.30B | 0.63% | 2,865,474 | 1.12B |
| 144 | DBVT | DBV Technologies S.A. | 1.24B | -1.25% | 105,834 | 5.64M |
| 145 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | -3.08% | 757,799 | - |
| 146 | SVRA | Savara Inc. | 1.23B | -3.39% | 1,100,096 | - |
| 147 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -7.68% | 2,051,113 | - |
| 148 | GHRS | GH Research PLC | 1.19B | -3.48% | 232,895 | - |
| 149 | PHAR | Pharming Group N.V. | 1.17B | -0.40% | 2,333 | 376.13M |
| 150 | ABCL | AbCellera Biologics Inc. | 1.16B | -8.17% | 11,839,140 | 75.13M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.16B | -3.30% | 561,006 | - |
| 152 | URGN | UroGen Pharma Ltd. | 1.14B | -3.23% | 492,272 | 109.79M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.10B | -15.61% | 1,132,783 | - |
| 154 | EYPT | EyePoint, Inc. | 1.07B | -4.53% | 805,717 | 31.37M |
| 155 | QURE | uniQure N.V. | 1.05B | -7.31% | 1,674,222 | 16.10M |
| 156 | SEPN | Septerna, Inc. | 1.05B | -3.46% | 347,610 | 45.95M |
| 157 | OMER | Omeros Corporation | 1.05B | -0.75% | 856,128 | - |
| 158 | ZBIO | Zenas BioPharma, Inc. | 1.04B | -2.55% | 498,518 | 10.00M |
| 159 | AKTS | Aktis Oncology, Inc. | 1.04B | 0.97% | 249,882 | 6.50M |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -1.15% | 1,080,846 | 291.85M |
| 161 | IVA | Inventiva S.A. | 1.02B | -1.40% | 146,762 | 7.94M |
| 162 | FTRE | Fortrea Holdings Inc. | 987.36M | -1.86% | 2,963,776 | 2.72B |
| 163 | DSGN | Design Therapeutics, Inc. | 973.81M | 23.26% | 2,691,450 | - |
| 164 | GERN | Geron Corporation | 967.76M | - | 11,191,911 | 183.88M |
| 165 | ANNX | Annexon, Inc. | 957.17M | -1.83% | 2,559,106 | - |
| 166 | ORIC | ORIC Pharmaceuticals, Inc. | 948.39M | -2.07% | 1,341,996 | - |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 935.69M | 3.97% | 2,933,819 | 175.11M |
| 168 | MRVI | Maravai LifeSciences Holdings, Inc. | 894.59M | -2.25% | 1,132,967 | 185.74M |
| 169 | SANA | Sana Biotechnology, Inc. | 891.72M | -2.99% | 3,977,384 | - |
| 170 | CTMX | CytomX Therapeutics, Inc. | 881.66M | -1.70% | 2,188,737 | 76.20M |
| 171 | LBRX | LB Pharmaceuticals Inc | 877.19M | -2.52% | 158,130 | - |
| 172 | EVMN | Evommune, Inc. | 859.04M | -6.76% | 237,664 | 13.00M |
| 173 | JANX | Janux Therapeutics, Inc. | 858.33M | -2.69% | 942,743 | 10.00M |
| 174 | TBPH | Theravance Biopharma, Inc. | 857.87M | -0.60% | 297,552 | 107.46M |
| 175 | DRUG | Bright Minds Biosciences Inc. | 854.82M | 0.13% | 164,370 | - |
| 176 | XNCR | Xencor, Inc. | 852.20M | -4.36% | 902,979 | 125.58M |
| 177 | ANRO | Alto Neuroscience, Inc. | 851.78M | -0.69% | 146,586 | - |
| 178 | MNKD | MannKind Corporation | 849.19M | -1.43% | 3,009,807 | 348.97M |
| 179 | SLS | SELLAS Life Sciences Group, Inc. | 838.65M | -4.30% | 3,491,217 | - |
| 180 | MGTX | MeiraGTx Holdings plc | 828.39M | -1.43% | 835,521 | 81.39M |
| 181 | TRAX | First Tracks Biotherapeutics, Inc. | 821.46M | 17.91% | 714,314 | - |
| 182 | ABUS | Arbutus Biopharma Corporation | 813.36M | -0.48% | 1,258,556 | 14.08M |
| 183 | SPRY | ARS Pharmaceuticals, Inc. | 778.49M | -1.26% | 919,891 | 84.28M |
| 184 | CGEM | Cullinan Therapeutics, Inc. | 777.76M | 0.31% | 726,204 | - |
| 185 | KURA | Kura Oncology, Inc. | 776.67M | -0.91% | 1,233,660 | 67.48M |
| 186 | RLMD | Relmada Therapeutics, Inc. | 773.03M | 1.80% | 846,804 | - |
| 187 | VOR | Vor Biopharma Inc. | 760.22M | -2.43% | 499,871 | - |
| 188 | TENX | Tenax Therapeutics, Inc. | 752.46M | -12.47% | 548,130 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 739.73M | -3.78% | 39,781 | - |
| 190 | ABSI | Absci Corporation | 732.16M | -3.09% | 3,726,278 | 2.80M |
| 191 | ALLO | Allogene Therapeutics, Inc. | 725.79M | -3.65% | 6,492,172 | 22.00K |
| 192 | CBIO | Crescent Biopharma, Inc. | 695.82M | -12.60% | 201,669 | 10.84M |
| 193 | SLDB | Solid Biosciences Inc. | 693.68M | -5.37% | 1,132,254 | - |
| 194 | FBRX | Forte Biosciences, Inc. | 686.12M | 6.23% | 323,503 | - |
| 195 | GYRE | Gyre Therapeutics, Inc. | 672.53M | -3.98% | 47,525 | 116.59M |
| 196 | LXRX | Lexicon Pharmaceuticals, Inc. | 656.70M | -6.63% | 1,565,002 | 49.80M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 648.63M | 0.96% | 248,862 | - |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 645.06M | -8.41% | 569,308 | - |
| 199 | ARVN | Arvinas, Inc. | 628.10M | -3.91% | 604,842 | 262.60M |
| 200 | PRME | Prime Medicine, Inc. | 625.32M | -4.34% | 1,220,694 | 4.63M |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 624.30M | 5.92% | 1,321,491 | 7.83M |
| 202 | CRMD | CorMedix Inc. | 586.64M | -1.19% | 1,002,625 | 311.71M |
| 203 | STRO | Sutro Biopharma, Inc. | 586.34M | 2.02% | 401,004 | 102.48M |
| 204 | PRTA | Prothena Corporation plc | 585.16M | -5.56% | 397,881 | 9.68M |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 571.64M | -2.32% | 964,535 | 106.47M |
| 206 | OCGN | Ocugen, Inc. | 568.71M | 1.20% | 3,259,076 | 4.41M |
| 207 | ANL | Adlai Nortye Ltd. | 563.60M | 15.78% | 585,388 | 5.00M |
| 208 | PROK | ProKidney Corp. | 549.57M | -0.55% | 617,741 | 893.00K |
| 209 | RIGL | Rigel Pharmaceuticals, Inc. | 539.99M | -4.38% | 265,098 | 294.28M |
| 210 | STTK | Shattuck Labs, Inc. | 535.87M | -5.84% | 697,125 | 1.00M |
| 211 | AGMB | AgomAb Therapeutics NV | 522.95M | 0.85% | 71,479 | - |
| 212 | ALT | Altimmune, Inc. | 510.74M | -4.01% | 4,516,713 | 41.00K |
| 213 | KYTX | Kyverna Therapeutics, Inc. | 508.45M | -3.45% | 756,008 | - |
| 214 | TECX | Tectonic Therapeutic, Inc. | 508.28M | -1.65% | 225,499 | - |
| 215 | UPB | Upstream Bio, Inc. | 499.85M | -3.42% | 415,823 | 2.85M |
| 216 | EIKN | Eikon Therapeutics, Inc. | 493.74M | 6.54% | 226,212 | - |
| 217 | XOMA | XOMA Royalty Corporation | 488.43M | 0.32% | 727,912 | 52.15M |
| 218 | LYEL | Lyell Immunopharma, Inc. | 483.83M | -3.49% | 56,029 | 36.00K |
| 219 | ADCT | ADC Therapeutics SA | 480.78M | 0.27% | 946,804 | 81.36M |
| 220 | FULC | Fulcrum Therapeutics, Inc. | 476.43M | -3.90% | 1,027,672 | 80.00M |
| 221 | ZURA | Zura Bio Limited | 475.35M | -5.47% | 666,835 | - |
| 222 | VSTM | Verastem, Inc. | 474.35M | -1.10% | 2,840,862 | 30.91M |
| 223 | ENGN | enGene Therapeutics Inc. | 474.29M | 1.72% | 344,624 | - |
| 224 | VALN | Valneva SE | 473.10M | -3.25% | 18,914 | 205.07M |
| 225 | OVID | Ovid Therapeutics Inc. | 465.47M | -0.37% | 1,378,314 | 7.25M |
| 226 | MDXG | MiMedx Group, Inc. | 458.33M | -9.26% | 3,019,155 | 418.63M |
| 227 | TRDA | Entrada Therapeutics, Inc. | 457.92M | -1.32% | 140,835 | 25.42M |
| 228 | IMMX | Immix Biopharma, Inc. | 457.49M | 0.35% | 595,435 | - |
| 229 | CADL | Candel Therapeutics, Inc. | 452.67M | -0.32% | 1,333,079 | - |
| 230 | LRMR | Larimar Therapeutics, Inc. | 450.85M | -1.36% | 1,570,460 | - |
| 231 | FDMT | 4D Molecular Therapeutics, Inc. | 449.76M | -6.48% | 740,030 | 85.21M |
| 232 | CTNM | Contineum Therapeutics, Inc. | 448.78M | -4.15% | 100,867 | - |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.33M | 3.23% | 141,274 | - |
| 234 | DNA | Ginkgo Bioworks Holdings, Inc. | 436.55M | -4.46% | 1,270,176 | 170.16M |
| 235 | RGNX | REGENXBIO Inc. | 433.58M | -3.34% | 558,531 | 170.44M |
| 236 | AVIR | Atea Pharmaceuticals, Inc. | 432.62M | -2.69% | 379,657 | - |
| 237 | AURA | Aura Biosciences, Inc. | 432.06M | -3.30% | 182,851 | - |
| 238 | PRLD | Prelude Therapeutics Incorporated | 429.36M | -2.73% | 454,120 | 12.14M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 420.81M | -2.24% | 365,541 | - |
| 240 | CLYM | Climb Bio, Inc. | 419.41M | -5.18% | 1,225,237 | - |
| 241 | ASMB | Assembly Biosciences, Inc. | 418.45M | -2.48% | 64,891 | 72.30M |
| 242 | VNDA | Vanda Pharmaceuticals Inc. | 416.71M | 3.07% | 1,079,403 | 216.11M |
| 243 | BNTC | Benitec Biopharma Inc. | 416.20M | -0.16% | 86,206 | - |
| 244 | NGNE | Neurogene Inc. | 413.51M | -3.53% | 246,245 | 925.00K |
| 245 | NMRA | Neumora Therapeutics, Inc. | 411.05M | - | 1,099,120 | - |
| 246 | PRTC | PureTech Health plc | 409.08M | -4.08% | 16,704 | 6.39M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 401.63M | 0.95% | 118,331 | 66.98M |
| 248 | IPSC | Century Therapeutics, Inc. | 396.13M | - | 463,135 | 109.16M |
| 249 | VTVT | vTv Therapeutics Inc. | 388.05M | -2.19% | 56,383 | 17.00K |
| 250 | IVVD | Invivyd, Inc. | 384.61M | -1.45% | 1,361,974 | 53.43M |
| 251 | NAGE | Niagen Bioscience, Inc. | 381.98M | -1.65% | 612,229 | 129.42M |
| 252 | PBYI | Puma Biotechnology, Inc. | 380.56M | -0.80% | 205,093 | 228.37M |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 379.75M | 1.46% | 2,126,555 | - |
| 254 | AUTL | Autolus Therapeutics plc | 375.26M | -4.73% | 1,609,768 | 75.39M |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 373.23M | -0.36% | 327,005 | 35.11M |
| 256 | YDES | YD Bio Limited | 364.92M | -0.20% | 1,564 | 510.36K |
| 257 | LCTX | Lineage Cell Therapeutics, Inc. | 363.67M | -6.41% | 2,242,202 | 14.56M |
| 258 | SRZN | Surrozen, Inc. | 362.52M | 1.87% | 129,519 | 3.48M |
| 259 | AVTX | Avalo Therapeutics, Inc. | 352.63M | 2.64% | 717,184 | 59.00K |
| 260 | ARMP | Armata Pharmaceuticals, Inc. | 349.84M | -2.15% | 70,177 | 4.90M |
| 261 | IMRX | Immuneering Corporation | 339.66M | 0.38% | 563,675 | - |
| 262 | SLN | Silence Therapeutics plc | 335.83M | -7.66% | 501,504 | 559.00K |
| 263 | MNPR | Monopar Therapeutics Inc. | 335.41M | -8.00% | 143,928 | - |
| 264 | IRD | Opus Genetics, Inc. | 333.45M | -6.60% | 1,668,365 | 14.20M |
| 265 | BCYC | Bicycle Therapeutics plc | 331.25M | 1.32% | 441,899 | 72.59M |
| 266 | RZLT | Rezolute, Inc. | 324.08M | 1.63% | 1,253,980 | - |
| 267 | PALI | Palisade Bio, Inc. | 323.13M | -1.03% | 2,185,389 | - |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 321.14M | -4.18% | 114,252 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 317.04M | -1.06% | 553,457 | 1.00 |
| 270 | NAUT | Nautilus Biotechnology, Inc. | 316.41M | -3.47% | 293,451 | - |
| 271 | CABA | Cabaletta Bio, Inc. | 309.48M | -2.80% | 2,341,959 | - |
| 272 | ABEO | Abeona Therapeutics Inc. | 303.75M | -0.37% | 786,754 | 5.82M |
| 273 | NGEN | NervGen Pharma Corp. | 303.49M | -3.35% | 217,373 | - |
| 274 | AVXL | Anavex Life Sciences Corp. | 302.11M | -3.26% | 587,058 | - |
| 275 | CMPX | Compass Therapeutics, Inc. | 300.75M | -9.24% | 24,705,590 | 850.00K |
| 276 | GLSI | Greenwich LifeSciences, Inc. | 299.26M | -5.26% | 154,927 | - |
| 277 | ACIU | AC Immune SA | 293.14M | -2.48% | 173,276 | 4.51M |
| 278 | LENZ | LENZ Therapeutics, Inc. | 283.76M | -2.58% | 587,670 | 19.09M |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 280.89M | -2.22% | 733,271 | 26.87M |
| 280 | SGMT | Sagimet Biosciences Inc. | 280.23M | -1.71% | 1,515,443 | - |
| 281 | NERV | Minerva Neurosciences, Inc. | 280.15M | -0.78% | 88,317 | - |
| 282 | TARA | Protara Therapeutics, Inc. | 279.62M | 2.17% | 516,051 | - |
| 283 | FHTX | Foghorn Therapeutics Inc. | 279.41M | -7.93% | 130,575 | 30.91M |
| 284 | EDIT | Editas Medicine, Inc. | 276.00M | -7.84% | 1,214,155 | 40.52M |
| 285 | CLLS | Cellectis S.A. | 273.38M | -6.50% | 22,404 | 79.59M |
| 286 | NBP | NovaBridge Biosciences | 271.77M | -1.67% | 4,697,575 | - |
| 287 | CHRS | Coherus Oncology, Inc. | 268.34M | -1.69% | 596,765 | 42.17M |
| 288 | CDXS | Codexis, Inc. | 255.34M | -0.35% | 1,321,578 | 70.39M |
| 289 | ALEC | Alector, Inc. | 253.83M | -3.77% | 368,602 | 21.05M |
| 290 | ELDN | Eledon Pharmaceuticals, Inc. | 253.73M | -4.02% | 1,185,774 | - |
| 291 | CCCC | C4 Therapeutics, Inc. | 249.80M | -6.91% | 1,849,270 | 35.95M |
| 292 | PLYX | Polaryx Therapeutics, Inc. | 247.13M | -7.28% | 72,621 | - |
| 293 | CGEN | Compugen Ltd. | 245.84M | -4.76% | 717,268 | 72.76M |
| 294 | HELP | Cybin Inc. | 245.68M | -4.84% | 1,261,259 | - |
| 295 | SABS | SAB Biotherapeutics, Inc. | 244.56M | -1.42% | 322,058 | 114.70K |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 238.75M | -5.30% | 251,856 | 82.03M |
| 297 | ADAG | Adagene Inc. | 234.56M | 0.57% | 385,584 | 7.67M |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 231.51M | -0.13% | 26,566 | 19.39M |
| 299 | NVCT | Nuvectis Pharma, Inc. | 225.18M | -2.19% | 47,060 | - |
| 300 | HRTX | Heron Therapeutics, Inc. | 224.48M | -1.65% | 1,214,872 | 154.90M |
| 301 | MIST | Milestone Pharmaceuticals Inc. | 223.22M | -1.62% | 655,919 | 1.55M |
| 302 | OBIO | Orchestra BioMed Holdings, Inc. | 222.38M | -2.56% | 241,990 | 33.48M |
| 303 | ACHV | Achieve Life Sciences, Inc. | 220.95M | -2.81% | 380,211 | - |
| 304 | KROS | Keros Therapeutics, Inc. | 219.64M | -2.37% | 209,685 | 244.06M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 217.24M | -3.32% | 343,781 | 40.37M |
| 306 | FENC | Fennec Pharmaceuticals Inc. | 215.81M | -6.42% | 141,830 | 44.64M |
| 307 | ARTV | Artiva Biotherapeutics, Inc. | 215.53M | -3.86% | 242,260 | 251.00K |
| 308 | CNTX | Context Therapeutics Inc. | 215.00M | -6.77% | 794,991 | - |
| 309 | ALXO | ALX Oncology Holdings Inc. | 212.60M | -3.66% | 381,976 | - |
| 310 | MDWD | MediWound Ltd. | 209.11M | -1.75% | 56,175 | 16.96M |
| 311 | CAMP | Camp4 Therapeutics Corporation | 206.66M | -6.79% | 56,831 | 3.50M |
| 312 | OKUR | OnKure Therapeutics, Inc. | 206.02M | -2.30% | 94,285 | - |
| 313 | OABI | OmniAb, Inc. | 197.63M | -2.50% | 527,865 | 18.67M |
| 314 | REPL | Replimune Group, Inc. | 196.52M | -7.39% | 4,019,649 | - |
| 315 | NKTX | Nkarta, Inc. | 191.77M | -2.89% | 866,203 | - |
| 316 | ELTX | Elicio Therapeutics, Inc. | 190.95M | -3.89% | 127,776 | - |
| 317 | WHWK | Whitehawk Therapeutics, Inc. | 190.67M | -2.18% | 64,297 | 7.15M |
| 318 | ENLV | Enlivex Ltd. | 190.26M | -2.97% | 372,506 | - |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 189.36M | -2.33% | 264,676 | 146.07M |
| 320 | MGNX | MacroGenics, Inc. | 186.55M | -2.49% | 423,879 | 149.50M |
| 321 | CRBU | Caribou Biosciences, Inc. | 185.54M | -7.69% | 1,170,493 | 11.16M |
| 322 | HUMA | Humacyte, Inc. | 182.06M | -3.24% | 3,462,702 | 2.04M |
| 323 | KRRO | Korro Bio, Inc. | 181.65M | -1.60% | 72,324 | 6.39M |
| 324 | UNCY | Unicycive Therapeutics, Inc. | 180.70M | -0.14% | 201,417 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 178.04M | -2.82% | 166,290 | 34.26M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 176.77M | -5.45% | 630,431 | - |
| 327 | TNXP | Tonix Pharmaceuticals Holding Corp. | 176.15M | -2.44% | 306,494 | 13.11M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 174.17M | - | 363,851 | - |
| 329 | RNAC | Cartesian Therapeutics, Inc. | 171.51M | -4.85% | 157,247 | 2.80M |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 170.81M | - | 497,275 | 52.74M |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 168.98M | -4.88% | 260,744 | - |
| 332 | ANTX | AN2 Therapeutics, Inc. | 168.64M | -1.16% | 177,008 | - |
| 333 | MENS | Jyong Biotech Ltd. | 167.64M | 1.38% | 26,212 | - |
| 334 | PRQR | ProQR Therapeutics N.V. | 162.26M | 4.05% | 1,127,965 | 19.19M |
| 335 | TLSA | Tiziana Life Sciences Ltd | 160.81M | 0.80% | 93,779 | - |
| 336 | MOLN | Molecular Partners AG | 159.10M | 3.97% | 1,323 | 856.30K |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 155.31M | -4.71% | 165,674 | 2.00M |
| 338 | ALPS | Alps Group Inc | 154.75M | -0.84% | 2,825 | 3.74M |
| 339 | SPRB | Spruce Biosciences, Inc. | 150.03M | 1.37% | 47,321 | 697.00K |
| 340 | GALT | Galectin Therapeutics Inc. | 148.11M | -3.02% | 265,011 | - |
| 341 | AGEN | Agenus Inc. | 147.45M | -1.29% | 538,796 | 114.20M |
| 342 | BDTX | Black Diamond Therapeutics, Inc. | 147.23M | -4.81% | 568,136 | 70.00M |
| 343 | SPRO | Spero Therapeutics, Inc. | 146.47M | -5.24% | 828,454 | 66.80M |
| 344 | FATE | Fate Therapeutics, Inc. | 144.17M | -4.62% | 911,976 | 6.65M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 143.28M | -4.44% | 3,234,078 | - |
| 346 | IFRX | InflaRx N.V. | 143.14M | 18.56% | 2,618,726 | 34.44K |
| 347 | CNTB | Connect Biopharma Holdings Limited | 143.00M | 5.42% | 124,869 | 64.00K |
| 348 | KZIA | Kazia Therapeutics Limited | 141.92M | 4.81% | 247,970 | 1.27M |
| 349 | EDSA | Edesa Biotech, Inc. | 141.28M | 11.50% | 2,246,194 | - |
| 350 | IMUX | Immunic, Inc. | 136.41M | -6.70% | 360,608 | - |
| 351 | HURA | TuHURA Biosciences, Inc. | 133.51M | -1.41% | 417,074 | - |
| 352 | EQ | Equillium, Inc. | 131.51M | 1.46% | 303,719 | 4.39M |
| 353 | IPHA | Innate Pharma S.A. | 131.03M | 5.71% | 67,418 | 10.57M |
| 354 | ACOG | Alpha Cognition Inc. | 128.47M | -4.84% | 28,492 | 10.22M |
| 355 | KLRS | Kalaris Therapeutics, Inc. | 125.42M | -2.93% | 91,720 | - |
| 356 | VRCA | Verrica Pharmaceuticals Inc. | 113.98M | 1.61% | 112,390 | 35.58M |
| 357 | AARD | Aardvark Therapeutics, Inc. | 113.37M | -7.04% | 106,501 | - |
| 358 | VANI | Vivani Medical, Inc. | 111.74M | -3.65% | 145,269 | - |
| 359 | GNLX | Genelux Corporation | 110.93M | -1.19% | 163,992 | 8.00K |
| 360 | CRDF | Cardiff Oncology, Inc. | 110.75M | -3.57% | 469,604 | 593.00K |
| 361 | PEPG | PepGen Inc. | 107.13M | -1.90% | 655,079 | - |
| 362 | NTHI | NeOnc Technologies Holdings, Inc. | 107.12M | -0.23% | 109,151 | 39.99K |
| 363 | SEER | Seer, Inc. | 106.07M | -2.59% | 280,425 | 16.58M |
| 364 | TTRX | Turn Therapeutics Inc. | 105.90M | -1.25% | 18,751 | - |
| 365 | CGTX | Cognition Therapeutics, Inc. | 105.44M | -7.81% | 956,290 | - |
| 366 | BMEA | Biomea Fusion, Inc. | 104.83M | -5.23% | 1,530,214 | - |
| 367 | PYXS | Pyxis Oncology, Inc. | 104.30M | -2.35% | 277,902 | 13.86M |
| 368 | KALA | KALA BIO, Inc. | 101.69M | -4.45% | 3,684,330 | - |
| 369 | ONCY | Oncolytics Biotech Inc. | 101.15M | -3.27% | 1,850,281 | - |
| 370 | PMN | ProMIS Neurosciences, Inc. | 99.99M | 2.76% | 34,807 | - |
| 371 | CBUS | Cibus, Inc. | 97.64M | -9.86% | 524,784 | 3.64M |
| 372 | ANIX | Anixa Biosciences, Inc. | 96.56M | -4.32% | 103,673 | - |
| 373 | NRXP | NRx Pharmaceuticals, Inc. | 96.13M | -1.36% | 469,351 | 1.23M |
| 374 | GUTS | Fractyl Health, Inc. | 95.51M | -8.27% | 3,106,130 | 3.00K |
| 375 | COYA | Coya Therapeutics, Inc. | 95.47M | -4.46% | 108,513 | 7.95M |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 91.77M | -2.61% | 1,038,433 | 65.34K |
| 377 | ALDX | Aldeyra Therapeutics, Inc. | 90.27M | -4.46% | 615,707 | - |
| 378 | EXOZ | eXoZymes, Inc. | 87.76M | 0.24% | 1,222 | -700.00 |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 87.19M | 0.63% | 437,336 | 1.63M |
| 380 | PYPD | PolyPid Ltd. | 86.45M | 2.26% | 41,591 | - |
| 381 | NRXS | NeurAxis, Inc. | 85.60M | -2.23% | 125,242 | 3.57M |
| 382 | PTHS | Pelthos Therapeutics Inc. | 84.19M | 0.48% | 12,117 | 16.80M |
| 383 | LONA | LeonaBio, Inc. | 82.38M | 0.92% | 37,202 | - |
| 384 | GOSS | Gossamer Bio, Inc. | 82.05M | 1.36% | 4,829,833 | 48.47M |
| 385 | ACET | Adicet Bio, Inc. | 82.02M | -0.52% | 100,644 | - |
| 386 | CSBR | Champions Oncology, Inc. | 81.24M | -1.01% | 577 | 57.95M |
| 387 | QTTB | Q32 Bio Inc. | 80.46M | -3.85% | 147,537 | 53.74M |
| 388 | OKYO | OKYO Pharma Limited | 79.77M | -3.80% | 49,391 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 78.87M | 4.00% | 1,181,052 | - |
| 390 | XBIT | XBiotech Inc. | 78.05M | 0.79% | 18,286 | - |
| 391 | ATHE | Alterity Therapeutics Limited | 78.00M | -0.43% | 19,297 | 4.43M |
| 392 | ICCC | ImmuCell Corporation | 75.90M | 0.48% | 16,323 | 27.64M |
| 393 | PLRX | Pliant Therapeutics, Inc. | 75.54M | 0.83% | 290,064 | - |
| 394 | ATYR | aTyr Pharma, Inc. | 75.01M | -3.60% | 999,753 | 190.00K |
| 395 | GANX | Gain Therapeutics, Inc. | 74.35M | -4.86% | 919,704 | - |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 74.13M | -2.11% | 205,052 | - |
| 397 | FBIO | Fortress Biotech, Inc. | 71.49M | -0.89% | 151,968 | 63.26M |
| 398 | IBO | Impact BioMedical Inc. | 71.16M | - | 69,533 | 32.00K |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 70.13M | -4.74% | 329,445 | - |
| 400 | FLNA | Filana Therapeutics, Inc. | 69.56M | -7.69% | 402,196 | - |
| 401 | TCRX | TScan Therapeutics, Inc. | 69.12M | -8.73% | 507,770 | 10.33M |
| 402 | OSTX | OS Therapies Incorporated | 68.52M | - | 574,666 | - |
| 403 | ACTU | Actuate Therapeutics, Inc. | 68.29M | -0.69% | 104,343 | - |
| 404 | MCRB | Seres Therapeutics, Inc. | 67.58M | -0.56% | 111,893 | 789.00K |
| 405 | MNOV | MediciNova, Inc. | 67.43M | 0.74% | 5,069 | 409.66K |
| 406 | IMA | ImageneBio, Inc. | 66.33M | 3.13% | 26,281 | 800.00K |
| 407 | IMMP | Immutep Limited | 66.24M | -2.01% | 676,346 | 5.28M |
| 408 | ANVS | Annovis Bio, Inc. | 63.54M | -0.54% | 646,334 | - |
| 409 | ESLA | Estrella Immunopharma, Inc. | 62.29M | -4.58% | 22,603 | - |
| 410 | BYSI | BeyondSpring Inc. | 60.45M | -2.65% | 5,793 | 1.88M |
| 411 | HYFT | MindWalk Holdings Corp. | 59.10M | -4.03% | 262,860 | 20.70M |
| 412 | INKT | MiNK Therapeutics, Inc. | 58.65M | 8.55% | 49,203 | - |
| 413 | IBIO | iBio, Inc. | 58.55M | -0.61% | 927,649 | 300.00K |
| 414 | SGMO | Sangamo Therapeutics, Inc. | 55.02M | -33.93% | 49,165,054 | 39.55M |
| 415 | CING | Cingulate Inc. | 54.77M | 0.64% | 670,535 | - |
| 416 | KZR | Kezar Life Sciences, Inc. | 54.04M | 0.07% | 67,619 | - |
| 417 | TIL | Instil Bio, Inc. | 53.98M | -1.49% | 12,250 | - |
| 418 | PDSB | PDS Biotechnology Corporation | 53.60M | -11.08% | 816,028 | - |
| 419 | ENTX | Entera Bio Ltd. | 52.22M | -0.88% | 83,013 | 42.00K |
| 420 | RADX | Radiopharm Theranostics Limited | 50.84M | -0.68% | 17,268 | 10.86M |
| 421 | MGX | Metagenomi Therapeutics, Inc. | 50.79M | -6.25% | 152,915 | 25.21M |
| 422 | TELO | Telomir Pharmaceuticals, Inc. | 49.85M | - | 200,597 | - |
| 423 | RLYB | Rallybio Corporation | 46.44M | -0.23% | 147,682 | 858.00K |
| 424 | NTRB | Nutriband Inc. | 46.07M | 0.80% | 8,694 | 2.28M |
| 425 | ATOS | Atossa Therapeutics, Inc. | 45.47M | -3.83% | 28,894 | - |
| 426 | HYPD | Hyperion DeFi, Inc. | 45.11M | -7.04% | 437,253 | 813.46K |
| 427 | DWTX | Dogwood Therapeutics, Inc. | 45.09M | - | 74,241 | - |
| 428 | XLO | Xilio Therapeutics, Inc. | 44.81M | -2.15% | 31,252 | 43.77M |
| 429 | MREO | Mereo BioPharma Group plc | 44.12M | -0.68% | 1,356,252 | 500.00K |
| 430 | CUE | Cue Biopharma, Inc. | 42.32M | 4.38% | 85,839 | 27.47M |
| 431 | LITS | Lite Strategy, Inc. | 41.82M | 0.88% | 258,764 | - |
| 432 | LIXT | Lixte Biotechnology Holdings, Inc. | 40.66M | -2.78% | 13,039 | - |
| 433 | PTN | Palatin Technologies, Inc. | 39.98M | -4.41% | 3,593 | 8.96M |
| 434 | PSTV | Plus Therapeutics, Inc. | 38.43M | -5.88% | 127,621 | 5.21M |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 37.93M | -2.78% | 26,128 | - |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 37.62M | -2.75% | 60,764 | 120.77M |
| 437 | RNXT | RenovoRx, Inc. | 37.44M | -1.06% | 419,863 | 1.12M |
| 438 | ALGS | Aligos Therapeutics, Inc. | 36.94M | -5.09% | 119,976 | 2.19M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 36.48M | -1.68% | 72,084 | 90.00K |
| 440 | VERU | Veru Inc. | 35.95M | -2.18% | 130,757 | 16.89M |
| 441 | RNTX | Rein Therapeutics Inc. | 35.75M | -12.07% | 671,889 | - |
| 442 | EVAX | Evaxion A/S | 35.53M | -1.39% | 7,371 | 7.53M |
| 443 | INMB | INmune Bio Inc. | 35.36M | -5.00% | 148,732 | 50.00K |
| 444 | PLUR | Pluri Inc. | 34.37M | 1.48% | 1,538 | 1.34M |
| 445 | CRVO | CervoMed Inc. | 33.79M | -1.62% | 26,221 | 4.01M |
| 446 | HOWL | Werewolf Therapeutics, Inc. | 33.05M | -8.11% | 445,890 | 1.14M |
| 447 | GRCE | Grace Therapeutics, Inc. | 32.50M | - | 468,440 | - |
| 448 | BOLD | Boundless Bio, Inc. | 32.49M | 0.69% | 67,525 | - |
| 449 | NXTC | NextCure, Inc. | 31.83M | -3.35% | 18,094 | - |
| 450 | QNTM | Quantum BioPharma Ltd. | 31.54M | 5.21% | 671,652 | - |
| 451 | SKYE | Skye Bioscience, Inc. | 31.41M | -3.87% | 148,626 | - |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 30.64M | 2.98% | 150,500 | 22.00K |
| 453 | IGC | IGC Pharma, Inc. | 30.61M | -1.18% | 318,498 | 1.11M |
| 454 | DARE | Daré Bioscience, Inc. | 30.57M | -4.11% | 226,093 | 1.03M |
| 455 | BCTX | BriaCell Therapeutics Corp. | 29.26M | -0.99% | 54,376 | - |
| 456 | LSTA | Lisata Therapeutics, Inc. | 29.08M | 0.63% | 61,535 | 170.00K |
| 457 | TVRD | Tvardi Therapeutics, Inc. | 28.71M | -4.38% | 32,706 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 28.53M | - | 3,887 | 6.44M |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 28.39M | -0.72% | 141,537 | - |
| 460 | APLM | Apollomics, Inc. | 28.07M | 1.75% | 2,242 | 8.99M |
| 461 | PLRZ | Polyrizon Ltd. | 28.03M | -4.73% | 34,490 | - |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 27.98M | 1.37% | 51,597 | 14.99M |
| 463 | CELU | Celularity Inc. | 27.68M | -7.69% | 46,967 | 40.58M |
| 464 | DYAI | Dyadic International, Inc. | 27.33M | -7.41% | 364,873 | 3.09M |
| 465 | OTLK | Outlook Therapeutics, Inc. | 26.82M | -2.17% | 3,440,913 | 205.70K |
| 466 | TVGN | Tevogen Bio Holdings Inc. | 26.73M | -1.08% | 10,588 | - |
| 467 | NNVC | NanoViricides, Inc. | 26.35M | 0.83% | 110,036 | - |
| 468 | ABVC | ABVC BioPharma, Inc. | 25.45M | -3.74% | 37,810 | 797.92K |
| 469 | LGVN | Longeveron Inc. | 25.34M | -2.10% | 127,878 | 1.20M |
| 470 | TPST | Tempest Therapeutics, Inc. | 24.96M | 2.96% | 118,277 | - |
| 471 | JSPR | Jasper Therapeutics, Inc. | 24.93M | -4.24% | 129,966 | - |
| 472 | BRNS | Barinthus Biotherapeutics plc | 24.51M | -1.66% | 11,234 | 14.97M |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.18M | 2.11% | 54,446 | 3.55M |
| 474 | AEON | AEON Biopharma, Inc. | 24.16M | -3.02% | 129,846 | - |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 23.61M | -0.12% | 377,621 | 789.00K |
| 476 | CVM | CEL-SCI Corporation | 23.55M | -4.28% | 83,557 | - |
| 477 | SER | Serina Therapeutics, Inc. | 22.53M | -1.08% | 62,533 | 130.00K |
| 478 | CRIS | Curis, Inc. | 22.44M | -3.56% | 540,381 | 9.44M |
| 479 | LTRN | Lantern Pharma Inc. | 22.19M | -11.61% | 210,584 | - |
| 480 | ALLR | Allarity Therapeutics, Inc. | 21.83M | 0.73% | 90,084 | 320.00K |
| 481 | VYNE | VYNE Therapeutics Inc. | 21.19M | -0.63% | 27,924 | 570.00K |
| 482 | XCUR | Exicure, Inc. | 21.10M | -4.61% | 24,835 | 500.00K |
| 483 | QNCX | Quince Therapeutics, Inc. | 20.05M | - | 983,833 | - |
| 484 | COCP | Cocrystal Pharma, Inc. | 19.16M | - | 113,831 | - |
| 485 | LPCN | Lipocine Inc. | 18.38M | -0.87% | 179,913 | 1.98M |
| 486 | CVKD | Cadrenal Therapeutics, Inc. | 17.21M | 4.88% | 58,415 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 17.18M | 2.17% | 267,068 | - |
| 488 | PASG | Passage Bio, Inc. | 17.16M | -7.44% | 88,701 | - |
| 489 | LEXX | Lexaria Bioscience Corp. | 17.08M | -21.93% | 791,339 | 368.00K |
| 490 | GNTA | Genenta Science S.p.A. | 16.63M | -1.99% | 21,825 | - |
| 491 | NCEL | NewcelX Ltd. | 15.59M | 2.09% | 20,961 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 15.46M | -1.28% | 53,962 | 1.23M |
| 493 | OSRH | OSR Holdings, Inc. | 15.24M | -38.19% | 10,178,376 | 2.91M |
| 494 | TOVX | Theriva Biologics, Inc. | 15.14M | -7.67% | 2,572,953 | - |
| 495 | INAB | IN8bio, Inc. | 14.87M | -1.31% | 94,845 | - |
| 496 | HIND | Vyome Holdings, Inc. | 14.32M | -2.86% | 20,930 | 319.71K |
| 497 | CYCN | Cyclerion Therapeutics, Inc. | 14.03M | 9.21% | 269,606 | 2.07M |
| 498 | PHIO | Phio Pharmaceuticals Corp. | 13.71M | -1.67% | 63,061 | - |
| 499 | HOTH | Hoth Therapeutics, Inc. | 13.67M | -2.70% | 337,964 | - |
| 500 | MBRX | Moleculin Biotech, Inc. | 13.39M | -1.95% | 76,257 | - |